Last checked at 9 Oct 2023 15:21
FORM 8.3 | |||||||
IRISH TAKEOVER PANEL | |||||||
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, | |||||||
TAKEOVER RULES, 2007 (AS AMENDED) | |||||||
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES | |||||||
REPRESENTING 1% OR MORE | |||||||
1. | KEY INFORMATION | ||||||
Name of person dealing (Note 1) | Barclays PLC. | ||||||
Company dealt in | HORIZON THERAPEUTICS PLC | ||||||
Class of relevant security to which the dealings being disclosed relate (Note 2) | $0.001 ordinary shares | ||||||
Date of dealing | 06 Oct 2023 | ||||||
2. | INTERESTS AND SHORT POSITIONS | ||||||
(a) | Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) | ||||||
Class of relevant security: | $0.001 ordinary shares | ||||||
Long | Short | ||||||
Number | (%) | Number | (%) | ||||
(1) | Relevant securities | 126,460 | 0.06% | 58,082 | 0.03% | ||
(2) | Derivatives (other than options): | 0 | 0.00% | 0 | 0.00% | ||
(3) | Options and agreements to purchase/sell: | 0 | 0.00% | 0 | 0.00% | ||
TOTAL: | 126,460 | 0.06% | 58,082 | 0.03% | |||
(b) | Interests and short positions in relevant securities of the company, other than the class dealt in | ||||||
Class of relevant security: | Long | Short | |||||
Number | (%) | Number | (%) | ||||
(1) | Relevant securities |
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
| ||
(3) | Options and agreements to purchase/sell: |
|
|
|
| ||
TOTAL: |
|
|
|
| |||
3. | DEALINGS (Note 4) | ||||||
(a) | Purchase and sales |
| |||||
Class of relevant Security | Purchase/sale | Number of securities | Price per unit | ||||
|
|
|
| ||||
| |||||||
(b) | Derivatives transactions (other than option transactions) | ||||||
Product Name | Nature of transaction | Number of relevant securities | Price per unit | ||||
|
|
|
| ||||
| |||||||
(c) | Options transactions in respect of existing securities | ||||||
(i) | Writing, selling, purchasing or varying | ||||||
Class of relevant security | Product description | Writing, purchasing, selling, varying etc | Number of securities to which option relates | Exercise price per unit | Type | Expiry date | Option money paid/ received per unit |
|
|
|
|
|
|
|
|
| |||||||
(ii) | Exercising |
| |||||
Product name | Number of securities | Exercise price per unit | |||||
|
|
| |||||
| |||||||
(d) | Other dealings (including transactions in respect of new securities) (Note 4) | ||||||
Nature of transaction | Details | Price per unit (if applicable) | |||||
|
|
| |||||
4. | OTHER INFORMATION | ||||||
Agreements, arrangements or understandings relating to options or derivatives | |||||||
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. | |||||||
NONE | |||||||
Is a Supplemental Form 8 (Open Positions) attached? | NO | ||||||
Date of disclosure: | 09 Oct 2023 | ||||||
Contact name: | Large Holdings Regulatory Operations | ||||||
Telephone number: | 020 3134 7213 | ||||||
If a connected EFM, name of offeree/offeror with which connected |
| ||||||
If a connected EFM, state nature of connection |
| ||||||